Procarbazine for non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 47, Issue 4, 2006, Pages 637-640

  Chaar, Bassem T ^a   Salem, Pascale ^a   Petruska, Paul J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alkylating agent; Monoamine oxidase inhibitor; Non Hodgkin's lymphoma; Procarbazine

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; INTERFERON; PREDNISONE; PROCARBAZINE; PROCHLORPERAZINE; PROTEIN BCL 2; RITUXIMAB; VINCRISTINE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW METASTASIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REGIMEN; DRUG MECHANISM; FATIGUE; GENE REARRANGEMENT; HUMAN; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAINTENANCE THERAPY; MALE; NAUSEA; NONHODGKIN LYMPHOMA; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PROCARBAZINE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION;

EID: 33646759263     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600591517     Document Type: Article

References (11)

1. Longo, D and Young, R and Hubbard, S and Wesley, M and Fisher, R and Jaffe, E and et al. (1984) Prolonged initial remission in patients with nodular mixed lymphoma Ann Intern Med, 100, pp. 651-656.
2. Ezdinli, E and Anderson, J and Melvin, F and Glick, J and Davis, T and O'Connell, M. (1985) Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma J Clin Oncol, 3, pp. 769-775.
3. Morgenfeld, M and Pavlovsky, A and Suarez, A and Somoza, N and Pavlovsky, S and Palau, M and Barros, C. (1975) Combined cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma Cancer, 36, pp. 1241-1249.
4. Ezdinli, E and Costello, W and Silverstein, M and Berard, C and Hartsock, R and Sokal, J. (1980) Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma Cancer, 46, pp. 29-33.
5. Glick, J and Barnes, J and Ezdinli, E and Berard, C and Orlow, E and Bennett, J. (1981) Nodular mixed lymphoma: Results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy Blood, 58, pp. 920-925.
6. Liang, R and Todd, D and Chan, T and Chiu, E and Lie, A and Ho, F. (1993) COPP chemotherapy for elderly patients with intermediate and high grade non-Hodgkin's lymphoma Hematol Oncol, 11, pp. 43-50.
7. Physician desk reference website. Available at: http://www.pdr.net/ druginformation/HomeSearchResults.aspx?SearchTerm=matulane. Accessed 10 February 2004
8. Newell, D and Gescher, A and Harland, S and Ross, D and Rutty, C. (1987) N-Methyl antitumour agents. A distinct class of anticancer drugs? Cancer Chemother Pharmacol, 19, pp. 91-102.
9. Sigma-tau Pharmaceuticals. Available at: http://www.sigmatau.com/ matulane/images/Prescribing_Information.pdf. Accessed 10 February 2006
10. Maxwell, M. (1980) Reexamining the dietary restrictions with procarbazine (an MAOI) Cancer Nurs, 3, pp. 451-457.
11. Fisher, R and LeBlanc, M and Press, O and Maloney, D and Unger, J and Miller, T. (2005) New treatment options have changed the survival of patients with follicular lymphoma J Clin Oncol, 23, pp. 8447-8452.